Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Single Blind, Placebo Controlled, Multicenter Study to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for the Treatment of Symptomatic, Visible Varicose Veins With Saphenofemoral Junction (SFJ) Incompetence.
Brief Summary: The purpose of this study is to evaluate the effectiveness of polidocanol injectable foam in the relief of symptoms, improvement of appearance, and overall effectiveness and safety in the treatment of varicose veins compared to placebo.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varisolve (Polidocanol Endovenous Microfoam) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Agitated Saline | Intervention Type: DRUG; Name: Varisolve (Polidocanol Endovenous Microfoam); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Agitated Saline; Assigned to Arm(s): 2
B: Arm Label: polidocanol injectable foam, 0.125%; Type: EXPERIMENTAL; Interventions: Drug: polidocanol injectable foam, 0.125% | Arm Label: polidocanol injectable foam, 0.5%; Type: EXPERIMENTAL; Interventions: Drug: polidocanol injectable foam, 0.5% | Arm Label: polidocanol injectable foam, 1.0%; Type: EXPERIMENTAL; Interventions: Drug: polidocanol injectable foam, 1.0% | Arm Label: Vehicle; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle | Intervention Type: DRUG; Name: polidocanol injectable foam, 0.125%; Assigned to Arm(s): polidocanol injectable foam, 0.125% | Intervention Type: DRUG; Name: polidocanol injectable foam, 0.5%; Assigned to Arm(s): polidocanol injectable foam, 0.5% | Intervention Type: DRUG; Name: polidocanol injectable foam, 1.0%; Assigned to Arm(s): polidocanol injectable foam, 1.0% | Intervention Type: DRUG; Name: Vehicle; Assigned to Arm(s): Vehicle
C: Arm Label: Polidocanol injectable foam 0.125%; Type: EXPERIMENTAL; Interventions: Drug: Polidocanol injectable foam (PEM) | Arm Label: Polidocanol injectable foam 0.5%; Type: EXPERIMENTAL; Interventions: Drug: Polidocanol injectable foam (PEM) | Arm Label: Polidocanol injectable foam 1.0%; Type: EXPERIMENTAL; Interventions: Drug: Polidocanol injectable foam (PEM) | Arm Label: Polidocanol injectable foam 2.0%; Type: EXPERIMENTAL; Interventions: Drug: Polidocanol injectable foam (PEM) | Arm Label: Vehicle; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Vehicle | Intervention Type: DRUG; Name: Polidocanol injectable foam (PEM); Assigned to Arm(s): Polidocanol injectable foam 0.125%, Polidocanol injectable foam 0.5%, Polidocanol injectable foam 1.0%, Polidocanol injectable foam 2.0% | Intervention Type: DRUG; Name: Placebo Vehicle; Assigned to Arm(s): Vehicle
D: Arm Label: EndoVenous Laser Ablation; Type: ACTIVE_COMPARATOR; Interventions: Device: EVLA, Drug: Lidocaine with 1:200,000 epinephrine solution, Drug: Sodium Bicarbonate | Arm Label: MechanoChemical Ablation (ClariVein®); Type: ACTIVE_COMPARATOR; Interventions: Device: ClariVein®, Drug: Lidocaine with 1:200,000 epinephrine solution, Drug: Sodium Tetradecyl Sulphate | Intervention Type: DEVICE; Name: EVLA; Assigned to Arm(s): EndoVenous Laser Ablation | Intervention Type: DEVICE; Name: ClariVein®; Assigned to Arm(s): MechanoChemical Ablation (ClariVein®) | Intervention Type: DRUG; Name: Lidocaine with 1:200,000 epinephrine solution; Assigned to Arm(s): EndoVenous Laser Ablation, MechanoChemical Ablation (ClariVein®) | Intervention Type: DRUG; Name: Lidocaine with 1:200,000 epinephrine solution; Assigned to Arm(s): EndoVenous Laser Ablation | Intervention Type: DRUG; Name: Sodium Bicarbonate; Assigned to Arm(s): EndoVenous Laser Ablation | Intervention Type: DRUG; Name: Sodium Tetradecyl Sulphate; Assigned to Arm(s): MechanoChemical Ablation (ClariVein®)

Answer: A